fluidigm.com - Rasio nilai perusahaan marang pendapatan LAB

Logo perusahaan publik Standard BioTools Inc (LAB)

Standard BioTools Inc. (LAB) valuation-to-revenue ratio correlates with geopolitical pressure restricting equipment exports to isolated regions. The -2478.38 mark characterizes this parameter amid cost optimization following the merger of two medtech assets. Meanwhile, high technological sophistication in mass cytometry and the possession of cell analysis patents create significant barriers to entry for new market players.

LAB Rasio nilai perusahaan marang pendapatan Standard BioTools Corp (23.11.2025 - 19.11.2026)

Rincian metrik keuangan lan pasar Fluidigm (LAB)

- rega saham lan konsensus proyeksi valuasi:
Pambiji fundamental perusahaan:Standard BioTools Inc. - LAB
Produk dadi Standard BioTools Inc

Standard BioTools Inc. (LAB) bases its business on the development of high-tech equipment for spatial biology. The EV/Sales metric compares the total value of assets and debt against the volume of generated sales. An increase in this ratio amid stagnant revenue signals overvaluation and the risk of a sharp price correction. It is critical for investors to track hidden institutional shifts through daily calculations. The current EV to revenue trend reflects market expectations regarding the company's engineering potential.

Analisis pesaing Standard BioTools Inc.

A (Agilent) - Rasio nilai perusahaan marang pendapatan|DGX (Quest Diagnostics) - Nilai perusahaan marang pendapatan|Illumina Inc (ILMN) - Multiplikator EV/Sales|Nilai perusahaan marang pendapatan EXAS|Revvity, Inc. (RVTY) - Rasio total nilai perusahaan marang pendapatan|Multiplikator EV/Sales BIO|NNNN (Anbio Biotechnology) - Nilai bisnis marang pendapatan|Multiplikator EV/Sales SHC (Sotera Health)|Quidel Corporation (QDEL) - Multiplikator nilai perusahaan marang pendapatan|OPK - Rasio nilai perusahaan marang pendapatan|Rasio total nilai perusahaan marang pendapatan CareDx Corp CDNA|Maravai LifeSciences (MRVI) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang dodolan Fulgent Genetics, Inc. FLGT|Rasio nilai perusahaan marang pendapatan Cytek Biosciences Inc|Multiplikator nilai perusahaan marang pendapatan OraSure OSUR|Nilai perusahaan marang pendapatan XGN (Exagen Diagnostics)|Rasio total nilai perusahaan marang pendapatan MDxHealth Inc.|Rasio nilai perusahaan marang pendapatan Lucid Diagnostics, Inc. LUCD|Prenetics Global Ltd (PRE) - Multiplikator nilai perusahaan marang pendapatan|Insight Molecular Diagnostics Inc - Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan trinitybiotech.com|PRPH (ProPhase) - Nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan AIMD|Nilai perusahaan marang pendapatan CODX|Multiplikator nilai perusahaan marang pendapatan heartsciences.com HSCS|Rasio nilai perusahaan marang pendapatan Biomerica Inc. (BMRA)|Rasio total nilai perusahaan marang pendapatan Cardio Diagnostics Holdings|Multiplikator EV/Sales ONCO (Onconetix Corporation)|Virax Biolabs Group (VRAX) - Multiplikator nilai perusahaan marang pendapatan|bluejaydx.com - Multiplikator EV/Sales|Aspira Women's Health - Koefisien nilai perusahaan marang pendapatan|AXDX (Accelerate Diagnostics) - Nilai perusahaan marang pendapatan|Nilai perusahaan marang pendapatan CENTOGENE, N.V.|Rasio nilai perusahaan marang pendapatan enzo.com|Multiplikator EV/Sales Fresh2 Group Limited|Multiplikator EV/Sales GENE|23andMe Holding Co. - Rasio nilai perusahaan marang pendapatan|Psychemedics Inc - Nilai perusahaan marang pendapatan